These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 19394232)
1. Studies on novel 2-imidazolidinones and tetrahydropyrimidin-2(1H)-ones as potential TACE inhibitors: design, synthesis, molecular modeling, and preliminary biological evaluation. DasGupta S; Murumkar PR; Giridhar R; Yadav MR Bioorg Med Chem; 2009 May; 17(10):3604-17. PubMed ID: 19394232 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, preliminary biological evaluation and molecular modeling of some new heterocyclic inhibitors of TACE. Sengupta P; Puri CS; Chokshi HA; Sheth CK; Midha AS; Chitturi TR; Thennati R; Murumkar PR; Yadav MR Eur J Med Chem; 2011 Nov; 46(11):5549-55. PubMed ID: 21963348 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE. Zhang C; Lovering F; Behnke M; Zask A; Sandanayaka V; Sun L; Zhu Y; Xu W; Zhang Y; Levin JI Bioorg Med Chem Lett; 2009 Jul; 19(13):3445-8. PubMed ID: 19464885 [TBL] [Abstract][Full Text] [Related]
4. Novel thiol-based TACE inhibitors. Part 2: Rational design, synthesis, and SAR of thiol-containing aryl sulfones. Bandarage UK; Wang T; Come JH; Perola E; Wei Y; Rao BG Bioorg Med Chem Lett; 2008 Jan; 18(1):44-8. PubMed ID: 18054488 [TBL] [Abstract][Full Text] [Related]
5. Structure and activity relationships of tartrate-based TACE inhibitors. Li D; Popovici-Muller J; Belanger DB; Caldwell J; Dai C; David M; Girijavallabhan VM; Lavey BJ; Lee JF; Liu Z; Mazzola R; Rizvi R; Rosner KE; Shankar B; Spitler J; Ting PC; Vaccaro H; Yu W; Zhou G; Zhu Z; Niu X; Sun J; Guo Z; Orth P; Chen S; Kozlowski JA; Lundell DJ; Madison V; McKittrick B; Piwinski JJ; Shih NY; Shipps GW; Siddiqui MA; Strickland CO Bioorg Med Chem Lett; 2010 Aug; 20(16):4812-5. PubMed ID: 20638281 [TBL] [Abstract][Full Text] [Related]
6. A molecular modeling analysis of novel non-hydroxamate inhibitors of TACE. Sheppeck JE; Tebben A; Gilmore JL; Yang A; Wasserman ZR; Decicco CP; Duan JJ Bioorg Med Chem Lett; 2007 Mar; 17(5):1408-12. PubMed ID: 17188861 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and immunosuppressive activity evaluation of substituted N-imidazolidin-2-ones and N-tetrahydropyrimidin-2(1H)-ones. Sabourin C; Robert JM J Enzyme Inhib Med Chem; 2008 Oct; 23(5):659-67. PubMed ID: 18821255 [TBL] [Abstract][Full Text] [Related]
8. Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation. Chun K; Park SK; Kim HM; Choi Y; Kim MH; Park CH; Joe BY; Chun TG; Choi HM; Lee HY; Hong SH; Kim MS; Nam KY; Han G Bioorg Med Chem; 2008 Jan; 16(1):530-5. PubMed ID: 17936631 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors. Gilmore JL; King BW; Harris C; Maduskuie T; Mercer SE; Liu RQ; Covington MB; Qian M; Ribadeneria MD; Vaddi K; Trzaskos JM; Newton RC; Decicco CP; Duan JJ Bioorg Med Chem Lett; 2006 May; 16(10):2699-704. PubMed ID: 16516466 [TBL] [Abstract][Full Text] [Related]
10. Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors. Duan JJ; Chen L; Lu Z; Xue CB; Liu RQ; Covington MB; Qian M; Wasserman ZR; Vaddi K; Christ DD; Trzaskos JM; Newton RC; Decicco CP Bioorg Med Chem Lett; 2008 Jan; 18(1):241-6. PubMed ID: 18032037 [TBL] [Abstract][Full Text] [Related]
11. A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors. Chen XT; Ghavimi B; Corbett RL; Xue CB; Liu RQ; Covington MB; Qian M; Vaddi KG; Christ DD; Hartman KD; Ribadeneira MD; Trzaskos JM; Newton RC; Decicco CP; Duan JJ Bioorg Med Chem Lett; 2007 Apr; 17(7):1865-70. PubMed ID: 17276676 [TBL] [Abstract][Full Text] [Related]
12. The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors. Rosner KE; Guo Z; Orth P; Shipps GW; Belanger DB; Chan TY; Curran PJ; Dai C; Deng Y; Girijavallabhan VM; Hong L; Lavey BJ; Lee JF; Li D; Liu Z; Popovici-Muller J; Ting PC; Vaccaro H; Wang L; Wang T; Yu W; Zhou G; Niu X; Sun J; Kozlowski JA; Lundell DJ; Madison V; McKittrick B; Piwinski JJ; Shih NY; Arshad Siddiqui M; Strickland CO Bioorg Med Chem Lett; 2010 Feb; 20(3):1189-93. PubMed ID: 20022498 [TBL] [Abstract][Full Text] [Related]
13. Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE). Duan JJ; Chen L; Lu Z; Jiang B; Asakawa N; Sheppeck JE; Liu RQ; Covington MB; Pitts W; Kim SH; Decicco CP Bioorg Med Chem Lett; 2007 Jan; 17(1):266-71. PubMed ID: 17027261 [TBL] [Abstract][Full Text] [Related]
14. Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships. Duan JJ; Chen L; Wasserman ZR; Lu Z; Liu RQ; Covington MB; Qian M; Hardman KD; Magolda RL; Newton RC; Christ DD; Wexler RR; Decicco CP J Med Chem; 2002 Nov; 45(23):4954-7. PubMed ID: 12408705 [TBL] [Abstract][Full Text] [Related]